| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |